The effect of formulation vehicles on the in vitro percutaneous permeation of ibuprofen

BMC Pharmacology

Volumn 11, Issue 1, 2011, Pages

  Stah, Jessica ^a   Wohlert, Mareike ^a   Kietzmann, Manfred ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; PHOSPHATE; DRUG VEHICLE; NONSTEROID ANTIINFLAMMATORY AGENT;

APPARENT PERMEABILITY; ARTICLE; CREAM; DRUG FORMULATION; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOLSTEIN-FRIESIAN CATTLE; IN VITRO STUDY; NONHUMAN; SKIN PERMEABILITY; ANALYSIS OF VARIANCE; CHEMISTRY; HUMAN; SKIN ABSORPTION;

ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; HUMANS; IBUPROFEN; PHARMACEUTICAL VEHICLES; SKIN ABSORPTION;

EID: 83355164013     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-11-12     Document Type: Article

References (15)

1. Hadgraft J: Skin, the final frontier 32. IntJPharm 2001, 224:1-18.
2. Magnusson BM, Anissimov YG, Cross SE, Roberts MS: Molecular size as the main determinant of solute maximum flux across the skin 4. JInvest Dermatol 2004, 122:993-999.
3. Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM: Human stratum corneum lipids: characterization and regional variations 3. JLipid Res 1983, 24:120-130.
4. Thong HY, Zhai H, Maibach HI: Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol 2007, 20:272-282.
5. Williams AC, Barry BW: Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 1992, 9:305-353.
6. Singh J, Singh S: Transdermal iontophoresis: effect of penetration enhancer and iontophoresis on drug transport and surface characteristics of human epidermis. Curr Probl Dermatol 1995, 22:179-183.
7. Srinivasan V, Higuchi WI, Sims SM, Ghanem AH, Behl CR: Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery. J Pharm Sci 1989, 78:370-375.
8. Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Molina-Trinidad E, Casas-Alancaster N, Revilla-Vazquez AL: Microneedles: A Valuable Physical Enhancer to Increase Transdermal Drug Delivery. J Clin Pharmacol . Table 2 Skin permeation parameters Formulation Recovery (%) Jmax (μ g/cm2/h) Lagtime (h) Skin absorption (μ g/cm2) Ibutop® gel 21 ± 5a 50 ± 23 0.0 ± 0.2ac 239 ± 159 Ibutop® cream 59 ± 8 65 ± 15 1.3 ± 0.6 57 ± 25 Ibuprofen solution 26 ± 8b 42 ± 16 1.3 ± 0.8 264 ± 192 Absorption parameters of bovine udder skin (recovery in the receptor chamber, Jmax, lagtime, and skin absorption) following application of different topical formulations containing ibuprofen 5%; n = 5-6, mean and standard deviation; p < 0.05 (One-way ANOVA followed by Tukey's multiple comparison test; a: gel vs. cream, b: solution vs. cream, c: gel vs. solution) Stahl et al. BMC Pharmacology 2011, 11:12 http://www.biomedcentral.com/1471-2210/11/12
9. Henry S, McAllister DV, Allen MG, Prausnitz MR: Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1999, 88:948.
10. Horhota ST, Fung HL: Percutaneous nitroglycerin absorption in rats 1. JPharmSci 1979, 68:608-612.
11. Hadgraft J, Whitefield M, Rosher PH: Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study. Skin Pharmacol Appl Skin Physiol 2003, 16:137-142.
12. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH: Ibuprofen Transport into and through Skin from Topical Formulations: In Vitro-In Vivo Comparison 1. J Invest Dermatol 2006.
13. OECD: OECD GUIDELINE FOR THE TESTING OF CHEMICALS (428): Skin absorption in vitro method. 2004.
14. Stahl J, Niedorf F, Kietzmann M: The correlation between epidermal lipid composition and morphologic skin characteristics with percutaneous permeation: an interspecies comparison of substances with different lipophilicity. J Vet Pharmacol Ther 2011, 34:502-507.
15. Niedorf F, Schmidt E, Kietzmann M: The automated, accurate and reproducible determination of steady-state permeation parameters from percutaneous permeation data. Altern Lab Anim 2008, 36:201-213.